Establishment of a monoclonal antibody for human LXRalpha: Detection of LXRalpha protein expression in human macrophages.

Yuichiro Watanabe, Toshiya Tanaka, Yasutoshi Uchiyama, Tetsu Takeno, Akashi Izumi, Hisahiko Yamashita, Junko Kumakura, Hiroko Iwanari, Jiang Shu-Ying, Makoto Naito, David J Mangelsdorf, Takao Hamakubo, Tatsuhiko Kodama
{"title":"Establishment of a monoclonal antibody for human LXRalpha: Detection of LXRalpha protein expression in human macrophages.","authors":"Yuichiro Watanabe,&nbsp;Toshiya Tanaka,&nbsp;Yasutoshi Uchiyama,&nbsp;Tetsu Takeno,&nbsp;Akashi Izumi,&nbsp;Hisahiko Yamashita,&nbsp;Junko Kumakura,&nbsp;Hiroko Iwanari,&nbsp;Jiang Shu-Ying,&nbsp;Makoto Naito,&nbsp;David J Mangelsdorf,&nbsp;Takao Hamakubo,&nbsp;Tatsuhiko Kodama","doi":"10.1186/1478-1336-1-1","DOIUrl":null,"url":null,"abstract":"<p><p>Liver X activated receptor alpha (LXRalpha) forms a functional dimeric nuclear receptor with RXR that regulates the metabolism of several important lipids, including cholesterol and bile acids. As compared with RXR, the LXRalpha protein level in the cell is low and the LXRalpha protein itself is very hard to detect. We have previously reported that the mRNA for LXRalpha is highly expressed in human cultured macrophages. In order to confirm the presence of the LXRalpha protein in the human macrophage, we have established a monoclonal antibody against LXRalpha, K-8607. The binding of mAb K-8607 to the human LXRalpha protein was confirmed by a wide variety of different techniques, including immunoblotting, immunohistochemistry, and electrophoretic mobility shift assay (EMSA). By immunoblotting with this antibody, the presence of native LXR protein in primary cultured human macrophage was demonstrated, as was its absence in human monocytes. This monoclonal anti-LXRalpha antibody should prove to be a useful tool in the analysis of the human LXRalpha protein.</p>","PeriodicalId":86148,"journal":{"name":"Nuclear receptor","volume":"1 1","pages":"1"},"PeriodicalIF":0.0000,"publicationDate":"2003-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1478-1336-1-1","citationCount":"30","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nuclear receptor","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1478-1336-1-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 30

Abstract

Liver X activated receptor alpha (LXRalpha) forms a functional dimeric nuclear receptor with RXR that regulates the metabolism of several important lipids, including cholesterol and bile acids. As compared with RXR, the LXRalpha protein level in the cell is low and the LXRalpha protein itself is very hard to detect. We have previously reported that the mRNA for LXRalpha is highly expressed in human cultured macrophages. In order to confirm the presence of the LXRalpha protein in the human macrophage, we have established a monoclonal antibody against LXRalpha, K-8607. The binding of mAb K-8607 to the human LXRalpha protein was confirmed by a wide variety of different techniques, including immunoblotting, immunohistochemistry, and electrophoretic mobility shift assay (EMSA). By immunoblotting with this antibody, the presence of native LXR protein in primary cultured human macrophage was demonstrated, as was its absence in human monocytes. This monoclonal anti-LXRalpha antibody should prove to be a useful tool in the analysis of the human LXRalpha protein.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人lxrα单克隆抗体的建立:检测人巨噬细胞中lxrα蛋白的表达。
肝X激活受体α (lxrα)与RXR形成功能性二聚体核受体,调节几种重要脂质的代谢,包括胆固醇和胆汁酸。与RXR相比,lxrα蛋白在细胞内的水平较低,而且lxrα蛋白本身很难被检测到。我们之前报道过LXRalpha的mRNA在人培养的巨噬细胞中高表达。为了证实lxrα蛋白在人巨噬细胞中的存在,我们建立了抗lxrα的单克隆抗体K-8607。mAb K-8607与人lxrα蛋白的结合被多种不同的技术证实,包括免疫印迹、免疫组织化学和电泳迁移量转移测定(EMSA)。用该抗体进行免疫印迹,证实了原生LXR蛋白在原代培养的人巨噬细胞中存在,而在人单核细胞中不存在。该单克隆抗lxrα抗体有望成为分析人lxrα蛋白的有效工具。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Treatment Strategy for Traumatic Brain Injury Depending on Severity In Expectation of a Tridemic: Circulation of ARVI Pathogens in the Republic of Belarus During the Epidemic Season 2022–2023 Structure and Analysis of the Nasal Pharmaceutical Market in Belarus Adaptation of Children in Kindergarten and Prevention of Repeated Respiratory Morbidity Antibacterial Therapy for Infectious Heart Diseases
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1